Hiroshi Yoshida
Department of Laboratory Medicine
Jikei University Kashiwa Hospital
163-1 Kashiwashita
Kashiwa
Japan
Name/email consistency: high
- Gender differences in the effects of Angiotensin receptor blockers on cardiovascular disease. Yoshida, H., Rosano, G., Shimizu, M., Mochizuki, S., Yoshimura, M. Curr. Pharm. Des. (2011)
- Sex differences in effects of valsartan administration on cardiovascular outcomes in hypertensive patients: findings from the Jikei Heart Study. Yoshida, H., Shimizu, M., Ikewaki, K., Taniguchi, I., Tada, N., Yoshimura, M., Rosano, G., Dahlöf, B., Mochizuki, S. J. Hypertens. (2010)
- Effects of supervised aerobic exercise training on serum adiponectin and parameters of lipid and glucose metabolism in subjects with moderate dyslipidemia. Yoshida, H., Ishikawa, T., Suto, M., Kurosawa, H., Hirowatari, Y., Ito, K., Yanai, H., Tada, N., Suzuki, M. J. Atheroscler. Thromb. (2010)
- Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Yoshida, H., Yanai, H., Ito, K., Tomono, Y., Koikeda, T., Tsukahara, H., Tada, N. Atherosclerosis (2010)
- Characteristic comparison of triglyceride-rich remnant lipoprotein measurement between a new homogenous assay (RemL-C) and a conventional immunoseparation method (RLP-C). Yoshida, H., Kurosawa, H., Hirowatari, Y., Ogura, Y., Ikewaki, K., Abe, I., Saikawa, S., Domitsu, K., Ito, K., Yanai, H., Tada, N. Lipids. Health. Dis (2008)
- Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. Yoshida, H., Yanai, H., Namiki, Y., Fukatsu-Sasaki, K., Furutani, N., Tada, N. CNS. Drug. Rev (2006)
- Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-mediated reduction in the expression of endothelial nitric oxide synthase. Yoshida, H., Sasaki, K., Namiki, Y., Sato, N., Tada, N. Atherosclerosis (2005)
- Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients. Yoshida, H., Hirowatari, Y., Kurosawa, H., Tada, N. Clin. Sci. (2005)
- Increased serum iron may contribute to enhanced oxidation of low-density lipoprotein in smokers in part through changes in lipoxygenase and catalase. Yoshida, H., Sasaki, K., Hirowatari, Y., Kurosawa, H., Sato, N., Furutani, N., Tada, N. Clin. Chim. Acta (2004)